Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients

NCT03053635 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG

Interventions

DRUG: TLD1433 infusion and photodynamic therapy (PDT) treatment

Sponsor

Theralase® Technologies Inc.

Collaborators

[object Object]
[object Object]
[object Object]